setmelanotide vs semaglutide Among participants 4 to 66 years of age with acquired hypothalamic obesity, setmelanotide, a melanocortin-4 receptor agonist, led to significantly greater reductions in body-mass index and hunger than placebo at 52 weeks Pharmacotherapy of obesity: an update

GLP-1s support overall cardiometabolic health and help reduce the risk of conditions like heart disease and sleep apnea before they develop, he explains

strength training) exercises

Consider switching to tirzepatide or exploring other weight loss peptide options

Plain water is inadequate for ESD: insufficient conductivity higher diathermy settings required Isotonic saline (0.9% NaCl): electrolyte-rich conductive medium facilitates cutting, coagulation and vessel precoagulation ESGE 2023 guidelines explicitly endorse saline over water in immersion-assisted ESD SITE-PCM: especially powerful combination the pocket stabilises the dissection plane, SITE optimises optics, buoyancy and diathermy performance Asclepius tube: continuous drainage of excess saline without repeated through-the-scope suctioning Western cohort data (181 lesions, Royal Free): R0 92.3%, curative resection 90.6%, 93.4% under conscious sedation, 0.5% surgery rate Conclusion: SITE is not a competitor to conventional ESD it is a flexible adjunct, most valuable in fibrotic lesions, anatomically challenging segments, and for broadening access to ESD without general anaesthesia

People looking for a standalone pill with no behavioral component should calibrate expectations accordingly

Amandeep Kahal, an obesity specialist with Kaiser Permanente, joined us on 'The Nine' to discuss the dangerous shift from viewing these drugs as essential medical treatments to casual, short-term solutions